πŸ‡ΊπŸ‡Έ FDA
Patent

US 11732005

Peptidomimetic proteasome inhibitors

granted A61KA61K38/00A61P

Quick answer

US patent 11732005 (Peptidomimetic proteasome inhibitors) held by Tri-Institutional Therapeutics Discovery Institute, Inc. expires Mon Aug 17 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Tri-Institutional Therapeutics Discovery Institute, Inc.
Grant date
Tue Aug 22 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 17 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K38/00, A61P, A61P35/04